These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 15589744

  • 1. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH.
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [Abstract] [Full Text] [Related]

  • 2. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 3. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T, Ljungman P, Brinch L, Lenhoff S, Lönnqvist B, Ringdén O, Ruutu P, Volin L, Albrechtsen D, Sallerfors B, Ebeling F, Myllylä G.
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [Abstract] [Full Text] [Related]

  • 4. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Yen TH, Huang CC, Lin HH, Huang JY, Tian YC, Yang CW, Wu MS, Fang JT, Yu CC, Chiang YJ, Chu SH.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
    [Abstract] [Full Text] [Related]

  • 5. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
    Zintl F, Färber I, Hermann J, Fuchs D, Prager J, Wutzler P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Apr; 116(3-4):557-64. PubMed ID: 2480308
    [Abstract] [Full Text] [Related]

  • 6. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R, Ross S, Hüsing J, Ottinger H, Elmaagacli A, Roggendorf M, Schaefer UW, Runde V.
    Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
    [Abstract] [Full Text] [Related]

  • 7. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
    Miller WJ, McCullough J, Balfour HH, Haake RJ, Ramsay NK, Goldman A, Bowman R, Kersey J.
    Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829
    [Abstract] [Full Text] [Related]

  • 8. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J, Wiśniewska M, Ciechanowski K, Rózański J, Domański L, Myslak M, Kamiński M, Sulikowski T, Pabisiak K, Romanowski M, Mizerski A, Tejchman K, Nowacki M, Ostrowski M, Bohatyrewicz R.
    Transplant Proc; 2006 Mar; 38(1):136-8. PubMed ID: 16504685
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
    Locasciulli A, Bruno B, Alessandrino EP, Meloni G, Arcese W, Bandini G, Cassibba V, Rotoli B, Morra E, Majolino I, Alberti A, Bacigalupo A, Italian Cooperative Group for Blood and Marrow Transplantation.
    Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
    [Abstract] [Full Text] [Related]

  • 10. Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation.
    Nebbia G, Mattes FM, Cholongitas E, Garcia-Diaz A, Samonakis DN, Burroughs AK, Emery VC.
    Liver Transpl; 2007 Jan; 13(1):130-5. PubMed ID: 17192909
    [Abstract] [Full Text] [Related]

  • 11. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
    Winston DJ, Ho WG, Bartoni K, Champlin RE.
    Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
    [Abstract] [Full Text] [Related]

  • 12. [Hepatitis virus infection and bone marrow transplantation].
    Huang XJ, Guo NL, Zheng R.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr; 16(3):166-70. PubMed ID: 7648643
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC, Lu PL, Hsiao HH, Chang CS, Liu TC, Yang WC, Lin SF.
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [Abstract] [Full Text] [Related]

  • 14. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T, Sakamaki S, Ishigaki S, Kohda K, Takeda M, Katoh J, Kuroda H, Hirayama Y, Kusakabe T, Akiyama T, Kuga T, Niitsu Y, Masaoka T, Sagawa T, Matsumoto Y.
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [Abstract] [Full Text] [Related]

  • 15. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 16. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies.
    Couriel D, Canosa J, Engler H, Collins A, Dunbar C, Barrett AJ.
    Bone Marrow Transplant; 1996 Aug; 18(2):347-53. PubMed ID: 8864445
    [Abstract] [Full Text] [Related]

  • 17. Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence.
    Guardia AC, Stucchi RS, Sampaio AM, Milan A, Costa SC, Pavan CR, Boin Ide F.
    Int J Infect Dis; 2012 Feb; 16(2):e124-9. PubMed ID: 22178541
    [Abstract] [Full Text] [Related]

  • 18. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.
    Würsch AM, Gratama JW, Middeldorp JM, Nissen C, Gratwohl A, Speck B, Jansen J, D'Amaro J, The TH, De Gast GC.
    Clin Exp Immunol; 1985 Nov; 62(2):278-87. PubMed ID: 3002684
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
    Bayram A, Ozkur A, Erkilic S.
    J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
    [Abstract] [Full Text] [Related]

  • 20. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.
    Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kato S, Kasahara S, Iseki T, Yamaguchi T, Tojo A, Asano S.
    Eur J Haematol; 2008 Mar; 80(3):251-7. PubMed ID: 18081702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.